Baixar PDF

Outros usuários também visualizaram estes artigos

Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice Carla Boquimpani; Fernanda Salles Seguro; Gustavo Henrique Romani Magalhães; Ingrid Luise Soares Pinto; Israel Bendit; Jaisson André Pagnoncelli Bortolini; Katia Borgia Barbosa Pagnano; Renato Centrone; Vaneuza Funke;
Hematol Transfus Cell Ther. 2022;44:402-9
Fulminant hepatitis secondary to nivolumab in a patient with Hodgkin¿s Lymphoma after complete remission Ana Júlia Negrelli dos Santos; Arthur Gomes Oliveira Braga; Talita Maira Bueno da Silveira;
10.1016/j.htct.2025.103983
REVERSAL OF ACCELERATED PHASE CML WITH HIGH BLAST COUNT FOLLOWING 5+2 CHEMOTHERAPY AND DASATINIB: A CASE REPORT Bü¿ra Akdo¿an; Ali Turunç; Birol Güvenç;
Hematol Transfus Cell Ther. 2025;47 Supl 2: